| ||
| RAS AND P53 EXPRESSION IN NON-SMALL-CELL LUNG-CANCER PATIENTS ... RAS AND P53 EXPRESSION IN NON-SMALL-CELL LUNG-CANCER PATIENTS - P53 OVER- EXPRESSION CORRELATES WITH A POOR PROGNOSIS. Authors: E PAPADAKIS, A MALLIRI, ... www.spandidos-publications.com/ijo/1/4/403 | ||
| Dr. David H. Harpole, Jr., M.D., Mesothelioma Pathologist A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression. ... www.mesotheliomaweb.org/mesothelioma/.../david-harpole-jr/ | ||
| Reflex testing for epidermal growth factor receptor mutation and ... Non-small cell lung cancer (NSCLC) is a poor-prognosis malignancy for which more effective treatments are needed, with accumulating clinical experiences ... www.ncbi.nlm.nih.gov/pubmed/21526964 |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment